These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24589354)

  • 1. Histopathological characteristics of human non-tumor thyroid tissues in a long-term model of adenomatous goiter xenografts in the NOD/Shi-scid, IL-2Rγ(null) mouse.
    Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
    Exp Toxicol Pathol; 2014 Jul; 66(4):203-9. PubMed ID: 24589354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of spontaneous lymphomas in non-experimental NOD/Shi-scid, IL-2Rγ
    Yasuda M; Ogura T; Goto T; Yagoto M; Kamai Y; Shimomura C; Hayashimoto N; Kiyokawa Y; Shinohara H; Takahashi R; Kawai K
    Exp Anim; 2017 Oct; 66(4):425-435. PubMed ID: 28679969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous thymic lymphomas in the non-obese diabetic/Shi-scid, IL-2R gamma (null) mouse.
    Kato C; Fujii E; Chen YJ; Endaya BB; Matsubara K; Suzuki M; Ohnishi Y; Tamaoki N
    Lab Anim; 2009 Oct; 43(4):402-4. PubMed ID: 19505936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodeficient NOD-scid IL-2Rγ(null) mice do not display T and B cell leakiness.
    Katano I; Ito R; Eto T; Aiso S; Ito M
    Exp Anim; 2011; 60(2):181-6. PubMed ID: 21512274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of human Graafian follicles following transplantation of human ovarian tissue into NOD/SCID/gammac null mice.
    Terada Y; Terunuma-Sato Y; Kakoi-Yoshimoto T; Hasegawa H; Ugajin T; Koyanagi Y; Ito M; Murakami T; Sasano H; Yaegashi N; Okamura K
    Am J Reprod Immunol; 2008 Dec; 60(6):534-40. PubMed ID: 19032615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
    Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
    Ito R; Katano I; Ida-Tanaka M; Kamisako T; Kawai K; Suemizu H; Aiso S; Ito M
    J Immunol; 2012 Nov; 189(9):4313-20. PubMed ID: 23018460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
    Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
    Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of human fetal liver-derived mesenchymal stem cells on CD34+ hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice.
    Yang HM; Cho MR; Sung JH; Yang SJ; Nam MH; Roh CR; Kim JM; Shin M; Song SH; Kwon CH; Joh JW; Kim SJ
    Transplant Proc; 2011 Jun; 43(5):2004-8. PubMed ID: 21693316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
    Ito M; Hiramatsu H; Kobayashi K; Suzue K; Kawahata M; Hioki K; Ueyama Y; Koyanagi Y; Sugamura K; Tsuji K; Heike T; Nakahata T
    Blood; 2002 Nov; 100(9):3175-82. PubMed ID: 12384415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
    Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
    Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is human leukocyte antigen-DR and intercellular adhesion molecule-1 expression on human thyrocytes constitutive in papillary thyroid cancer? Comparative studies in human thyroid xenografts in severe combined immunodeficient and nude mice.
    Kawai K; Resetkova E; Enomoto T; Fornasier V; Volpé R
    J Clin Endocrinol Metab; 1998 Jan; 83(1):157-64. PubMed ID: 9435434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice.
    Suemizu H; Hasegawa M; Kawai K; Taniguchi K; Monnai M; Wakui M; Suematsu M; Ito M; Peltz G; Nakamura M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):248-52. PubMed ID: 18840406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
    André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
    J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of EBV-related lymphoproliferative lesions arising in donor lymphocytes of transplanted human tumor tissues in the NOG mouse.
    Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
    Exp Anim; 2014; 63(3):289-96. PubMed ID: 25077758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous Tax-specific CTL therapy in a primary adult T cell leukemia/lymphoma cell-bearing NOD/Shi-scid, IL-2Rγnull mouse model.
    Masaki A; Ishida T; Suzuki S; Ito A; Mori F; Sato F; Narita T; Yamada T; Ri M; Kusumoto S; Komatsu H; Tanaka Y; Niimi A; Inagaki H; Iida S; Ueda R
    J Immunol; 2013 Jul; 191(1):135-44. PubMed ID: 23733874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
    Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
    Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice.
    Hamada K; Monnai M; Kawai K; Nishime C; Kito C; Miyazaki N; Ohnishi Y; Nakamura M; Suemizu H
    Int J Oncol; 2008 Jan; 32(1):153-9. PubMed ID: 18097554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The status of donor cancer tissues affects the fate of patient-derived colorectal cancer xenografts in NOG mice.
    Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
    Exp Anim; 2015; 64(2):181-90. PubMed ID: 25740629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γcnull mouse.
    Suzuki M; Takahashi T; Katano I; Ito R; Ito M; Harigae H; Ishii N; Sugamura K
    Int Immunol; 2012 Apr; 24(4):243-52. PubMed ID: 22402880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.